Flt3 ligand supports the differentiation of early B cell progenitors in the presence of interleukin-11 and interleukin-7

Eur J Immunol. 1996 Jul;26(7):1504-10. doi: 10.1002/eji.1830260715.

Abstract

B cell development is influenced by interactions between B cell progenitors and stromal cells. The precise mechanisms by which these interactions regulate B cell differentiation are currently unknown. Flt3 ligand (FL) is a growth factor which stimulates the proliferation of stem cells and early progenitors. Mice deficient for the FLT3 receptor exhibit severe reductions in early B lymphoid progenitors. We have previously described a clonal assay in vitro which allows us to follow the entire B cell differentiation pathway from uncommitted progenitors to mature, immunoglobulin-secreting plasma cells. The growth factor combination of interleukin (IL)-11, mast cell growth factor (MGF) and IL-7 was shown to maintain the differentiation of these hematopoietic precursors into B cell progenitors capable of giving rise to functionally mature B cells in secondary cultures. Here, we show that FL in combination with IL-11 and IL-7 is sufficient to support the differentiation of uncommitted progenitors from day 10 yolk sac (AA4.1+) or day 12 fetal liver (AA4.1+ B220- Mac-1- Sca-1+) into the B lineage. The frequency of B cell progenitors obtained in these conditions was similar, if not better, than the frequency of B cell precursors that arose when cultured in IL-11+MGF+IL-7. Furthermore, the growth factor combination of IL-11+FL+ IL-7 was able to maintain the potential of bipotent precursors giving rise to both the B and myeloid lineages in secondary cultures. We also show that FL synergizes with IL-7 in the proliferation of committed B220+ pro-B cells and may contribute to the maintenance of an earlier pro-B cell population. Together, these results show that FL is important in supporting the differentiation and proliferation of early B cell progenitors in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocyte Subsets / cytology
  • B-Lymphocyte Subsets / drug effects
  • B-Lymphocytes / cytology*
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Cell Differentiation / drug effects
  • Cell Differentiation / immunology
  • Drug Synergism
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / drug effects*
  • Hematopoietic Stem Cells / immunology
  • Interleukin-11 / pharmacology*
  • Interleukin-7 / pharmacology*
  • Ligands
  • Mice
  • Mice, Inbred C57BL
  • Proto-Oncogene Proteins / pharmacology*
  • Receptor Protein-Tyrosine Kinases / pharmacology*
  • Receptors, Cell Surface / immunology
  • Receptors, Cell Surface / metabolism
  • Stem Cell Factor / pharmacology
  • Yolk Sac / cytology
  • fms-Like Tyrosine Kinase 3

Substances

  • Interleukin-11
  • Interleukin-7
  • Ligands
  • Proto-Oncogene Proteins
  • Receptors, Cell Surface
  • Stem Cell Factor
  • Flt3 protein, mouse
  • Receptor Protein-Tyrosine Kinases
  • fms-Like Tyrosine Kinase 3